Anti-pd-l1 antibodies and their use to enhance t-cell function

KR101782570B1 · office KR · priority 2008-12-09 · published 2017-09-27

The present application discloses an anti-PD-L1 antibody, a nucleic acid encoding the same, therapeutic compositions thereof, and a method of enhancing T cell function to upregulate a cell mediated immune response and to treat T (including acute and chronic) To the use thereof for the treatment of …

Inventor: 브라이언 어빙 · Assignee: 제넨테크, 인크.

Open the patent document · source query “cold chain vaccine”